Hedieh Barkhordarian

Hedieh Barkhordarian

Auto-generated profile, based on publicly available information

Hedieh Barkhordarian

Drug Substance Technologies, Process Development, Amgen Inc., Thousand Oaks, CA, 91320

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2018 in Biotechnology Progress
Verified
Journal Article
Open access
PDF file
KLKim Le
Kim Le
CTChristopher Tan
Christopher Tan
SGShivani Gupta
Shivani Gupta
TGTrupti Guhan
Trupti Guhan
HBHedieh Barkhordarian
Hedieh Barkhordarian
TMTrent Munro
Trent Munro
Generating a highly productive cell line is resource intensive and typically involves long timelines because of the need to screen large numbers of candidates in protein production studies. This has led to miniaturization and automation strategies to allow for reductions in resources and higher throughput. Current approaches rely on the use of standard cell culture vessels and bulky liquid handling equipment. New nanofludic technologies offer novel solutions to surpass these limits, further miniaturizing cell culture volumes (10 5 times smaller) by growing cells on custom nanofluidic chips. Berkeley Lights’ OptoElectro Positioning technology projects light patterns to activate photoconductors that gently repel cells to manipulate single cells on nanofluidic culturing chips. Using a fully integrated technology platform (Beacon), common cell culture tasks can be programmed through software, allowing maintenance and analysis of thousands of cell lines in parallel on a single chip. Here, we describe the ability to perform key cell line development work on the Beacon platform. We demonstrate that commercial production Chinese hamster ovary cell lines can be isolated, cultured, screened, and exported at high efficiency. We compare this process head to head with a FACS‐enabled microtiter plate‐based workflow and demonstrate generation of comparable clonal cell lines with reduced resources. © 2018 American Institute of Chemical Engineers Biotechnol. Prog ., 34:1438–1446, 2018

1 May 2018 in Biotechnology Progress
Verified
Journal Article
Open access
PDF file
TTTharmala Tharmalingam
Tharmala Tharmalingam
HBHedieh Barkhordarian
Hedieh Barkhordarian
NTNicole Tejeda
Nicole Tejeda
KDKristi Daris
Kristi Daris
SYSam Yaghmour
Sam Yaghmour
JSJennitte Stevens
Jennitte Stevens
Regulatory guidelines require the sponsors to provide assurance of clonality of the production cell line, and when such evidence is not available, additional studies are typically required to further ensure consistent long‐term manufacturing of the product. One potential approach to provide such assurance of clonal derivation of a production cell line is to characterize subclones generated from the original cell line and assess their phenotypic and genotypic similarity with the hypothesis that cell lines derived from a clonal bank will share performance, productivity and product quality characteristics. In this study, a production cell line that was cloned by a validated FACS approach coupled with day 0 imaging for verification of single‐cell deposition was subcloned using validated FACS and imaging methods. A total of 46 subclones were analyzed for growth, productivity, product quality, copy number, and integration site analysis. Significant diversity in cell growth, protein productivity, product quality attributes, and copy number was observed between the subclones, despite stability of the parent clone over time. The diversity in protein productivity and quality of the subclones were reproduced across time and production scales, suggesting that the resulting population post sub‐cloning originating from a single cell is stable but with unique properties. Overall, this work demonstrates that the characteristics of isolated subclones are not predictive of a clonally derived parental clone. Consequently, the analysis of subclones may not be an effective approach to demonstrate clonal origin of a cell bank. © 2018 American Institute of Chemical Engineers Biotechnol. Prog. , 34:613–623, 2018

9 May 2012 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
KHKatariina M. Hutterer
Katariina M. Hutterer
ZZZhongqi Zhang
Zhongqi Zhang
MMMark Leo Michaels
Mark Leo Michaels
EBEd Belouski
Ed Belouski
RHRobert W. Hong
Robert W. Hong
JLJennifer Liu
Jennifer Liu